COVID-19: MEPs want to ensure developing countries’ access to vaccines | Nieuws | Europees Parlement

Huidige taal: NL - Nederlands  
 

COVID-19: MEPs want to ensure developing countries’ access to vaccines  

Persbericht 
 
 

COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

“Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


“The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


Vaccine manufacturing in developing countries


Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


Quote


“We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


Background


In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

 
Huidige taal: NL - Nederlands  
  • Direct naar de inhoud van de pagina (druk op "Enter") 
  • Direct naar de inhoud van de pagina (druk op "Enter") Direct naar de inhoud van de pagina (druk op "Enter") 
  • Rechtstreeks naar talenmenu (druk op "Enter") 
  • Rechtstreeks naar talenmenu (druk op "Enter") Rechtstreeks naar talenmenu (druk op "Enter") 
  • Rechtstreeks naar zoekmenu (druk op "Enter") 
  • Rechtstreeks naar zoekmenu (druk op "Enter") Rechtstreeks naar zoekmenu (druk op "Enter") 
    Huidige taal: NL - Nederlands  
    Huidige taal: NL - Nederlands  
    Huidige taal: NL - Nederlands  
    Huidige taal: NL - Nederlands  
    Taal kiezen 
    Huidige taal: NL - Nederlands  
    Huidige taal: NL - Nederlands  
    Huidige taal:NL - Nederlands Selecteer 
    Andere websites 
    Andere websites bekijken  Andere websites bekijken 
    Andere websites 
    Andere websites  Andere websites bekijken  Andere websites bekijken  Andere websites bekijken  Andere websites bekijken 
    1. Nieuws 
    2. Leden 
    3. Over het Parlement 
    4. Plenaire vergadering 
    5. Commissies 
    6. Delegaties 
    7. Andere websitesMeer 
      BekijkenAndere websitesMeer  Andere websitesMeer 
  • Nieuws 
  • Nieuws  Nieuws 
  • Leden 
  • Leden  Leden 
  • Over het Parlement 
  • Over het Parlement  Over het Parlement 
  • Plenaire vergadering 
  • Plenaire vergadering  Plenaire vergadering 
  • Commissies 
  • Commissies  Commissies 
  • Delegaties 
  • Delegaties  Delegaties 
  • Andere websitesMeer 
    BekijkenAndere websitesMeer  Andere websitesMeer 
  • Andere websitesMeer 
    BekijkenAndere websitesMeer  Andere websitesMeer 
    Andere websitesMeer 
    Andere websitesMeerAndere websitesMeer BekijkenAndere websitesMeer BekijkenAndere websitesMeerBekijkenAndere websitesMeer Andere websitesMeer Andere websitesMeerAndere websitesMeer 
    1. Multimedia Centre 
    2. Webpagina van de Voorzitter 
    3. Secretariaat-generaal 
    4. Think tank 
    5. EP Newshub 
    6. Tot uw dienst 
    7. Bezoeken 
    8. Legislative train 
    9. Contracten en subsidies 
    10. Registreren 
  • Multimedia Centre 
  • Multimedia Centre Multimedia Centre 
  • Webpagina van de Voorzitter 
  • Webpagina van de Voorzitter Webpagina van de Voorzitter 
  • Secretariaat-generaal 
  • Secretariaat-generaal Secretariaat-generaal 
  • Think tank 
  • Think tank Think tank 
  • EP Newshub 
  • EP Newshub EP Newshub 
  • Tot uw dienst 
  • Tot uw dienst Tot uw dienst 
  • Bezoeken 
  • Bezoeken Bezoeken 
  • Legislative train 
  • Legislative train Legislative train 
  • Contracten en subsidies 
  • Contracten en subsidies Contracten en subsidies 
  • Registreren 
  • Registreren Registreren Andere websites verbergenAndere websitesMeer Andere websites verbergenAndere websitesMeerAndere websites verbergenAndere websitesMeer  Andere websites verbergen  Andere websites verbergen  Nieuws  Nieuws  Europees Parlement  Europees Parlement  
    Navigatiebalk (Menu)  
    Navigatiebalk (Menu)  
    Navigatiebalk (Menu)   Navigatiebalk (Menu) Navigatiebalk ()  Navigatiebalk (Menu)   Navigatiebalk (Menu) Navigatiebalk () 
    1. Nieuws  Nieuws 
    2. Pers  Pers 
    3. Agenda  Agenda 
  • Nieuws  Nieuws 
  • Nieuws  Nieuws 
    Nieuws Nieuws Nieuws Nieuws 
    Startpagina  Startpagina  Categorie:Europese zaken  Categorie:Europese zakenCategorie:  Categorie:Wereld  Categorie:WereldCategorie:  Categorie:Economie  Categorie:EconomieCategorie:  Categorie:Maatschappij  Categorie:MaatschappijCategorie:  Categorie:Veiligheid  Categorie:VeiligheidCategorie:  Menu sluiten  Menu sluiten 
  • Pers  Pers 
  • Pers  Pers 
    Pers Pers  Pers  Pers 
    Startpagina   Startpagina Accreditatie Accreditatie Contact Contact Close(Pers) Close(Pers)(Pers) 
  • Agenda  Agenda 
  • Agenda  Agenda 
    Agenda Agenda  Agenda  Agenda 
    Hoogtepunten Hoogtepunten Wekelijkse agenda Wekelijkse agenda Briefing Briefing Menu sluiten Menu sluiten  Veelgestelde vragen  Veelgestelde vragen  #EuropeanenTegenCovid19  #EuropeanenTegenCovid19  Sluit de navigatiebalk(Menu)  Sluit de navigatiebalk(Menu)Sluit de navigatiebalk()   
    Naar het zoekveld   Naar het zoekveld Search 
    Zoekopdracht starten  Sluit het zoekveld   Sluit het zoekveld 
    Pers   > Huidige pagina: COVID-19: MEPs want to ensure developing countries’ access to vaccines  
    Pers   > Pers  Pers > Huidige pagina: COVID-19: MEPs want to ensure developing countries’ access to vaccines   Huidige pagina: COVID-19: MEPs want to ensure developing countries’ access to vaccines   Huidige pagina:COVID-19: MEPs want to ensure developing countries’ access to vaccines   Pers  Pers >
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    Persbericht 
     
     

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

     
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    Persbericht 
     
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    Persbericht 
     
     
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    Persbericht 
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    Persbericht 
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    Persbericht 
     

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  

    COVID-19: MEPs want to ensure developing countries’ access to vaccines  
    COVID-19: MEPs want to ensure developing countries’ access to vaccines  
    Persbericht 
     
    Persbericht 
    Persbericht  DEVE  DEVEDEVE 
     
     
     

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

     
     

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

     
     
     

    Deel deze pagina: 

    Deel deze pagina: 
    Deel deze pagina: 
  • Facebook Facebook 
  • Twitter Twitter 
  • LinkedIn LinkedIn 
  • Whatsapp Whatsapp 

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    COVID-19 vaccines should be produced also in developing countries to overcome the pandemic, development MEPs told Commissioner Urpilainen on Thursday.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.


    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.


    Vaccine manufacturing in developing countries


    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote


    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.


    Background


    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.


    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    “Distributing vaccines globally is our exit strategy from the pandemic,” International Partnership Commissioner Jutta Urpilainen told the Development Committee, adding that the Commission will coordinate a “common EU vaccine sharing mechanism”, in which EU countries can donate part of their vaccines through the COVAX program, especially when vaccine production is scaled up.

    COVAX program

    The EU is also seeking to scale up production capacity in developing countries and to contribute to strengthening their regulatory framework in the pharmaceutical field, she said.


    “The main tool that the EU can help developing countries with” remains the COVAX assistance program, which aims to deliver vaccines to poorer countries and to which the EU contributed by €850 million, said the commissioner. She announced that COVAX will start deliveries to 18 countries, including 12 low and medium income ones, by the end of February, Urpileinen added.

    COVAX will start deliveries

    Vaccine manufacturing in developing countries

    Vaccine manufacturing in developing countries

    Welcoming EU’s involvement in the COVAX assistance program and its focus on distributing vaccines to developing countries in need, several MEPs nevertheless questioned the strategy of vaccine sharing, pointing to current shortage of vaccine doses in the EU itself.


    Some speakers pressed for suspending vaccine patents as a way out: the EU must allow developing countries to produce their own inexpensive vaccinations instead of relying on EU charity, they said.


    Quote

    Quote

    “We need to fight this pandemic globally as no single nation or even a united EU will be able to solve the crisis alone. It has an immense impact on the developing world, and the full range of consequences is not yet known. We know that developing countries are at risk of losing ten years of progress if nothing is done. If we are to combat this virus effectively, the vaccine has to be available for all. We are calling on the EU to take the lead in enhanced global cooperation and emphasising the role of widespread immunisation against COVID-19 as a global public health good," said Tomas Tobé (EPP, SE), the chair of the Committee on Development.

    Tomas Tobé

    Background

    Background

    In an upcoming draft report, the committee is set to ask for substantial new funds to assist developing countries worldwide in their fight against COVID-19, including by making vaccines available globally. Last spring, Development Committee Chair Tomas Tobé called for such action, and the committee urged the international community to protect the most vulnerable.

    upcoming draft reportcalled for such actionprotect the most vulnerable

    In a debate in November 2020, the GAVI Alliance told  the committee the COVAX assistance program they lead planned to deliver two billion doses of safe, effective COVID-19 vaccines by the end of 2021.

    GAVI Alliancetwo billion doses of safe, effective COVID-19 vaccines

    Contact: 

    Contact: 
    Contact: 
  • Eszter BALÁZS 

    Eszter BALÁZS Eszter BALÁZS 
    Press Officer 
    Press Officer Press Officer 
    Contactgegevens: 
    Contactgegevens: 
  • Telefoonnummer: (+32) 2 28 42373 (BXL) 
  • Telefoonnummer: (+32) 2 28 42373 (BXL) Telefoonnummer: (+32) 2 28 42373 (BXL)Telefoonnummer: (BXL) 
  • Telefoonnummer: (+33) 3 881 73839 (STR) 
  • Telefoonnummer: (+33) 3 881 73839 (STR) Telefoonnummer: (+33) 3 881 73839 (STR)Telefoonnummer: (STR) 
  • Mobiel telefoonnummer: (+32) 470 88 08 77 
  • Mobiel telefoonnummer: (+32) 470 88 08 77 Mobiel telefoonnummer: (+32) 470 88 08 77Mobiel telefoonnummer:  
  • E-mail: eszter.balazs@europarl.europa.eu 
  • E-mail: eszter.balazs@europarl.europa.eu E-mail: eszter.balazs@europarl.europa.euE-mail:  
  • E-mail: deve-press@europarl.europa.eu 
  • E-mail: deve-press@europarl.europa.eu E-mail: deve-press@europarl.europa.euE-mail:  
  • Twitteraccount: @EP_Development 
  • Twitteraccount: @EP_Development Twitteraccount: @EP_DevelopmentTwitteraccount:  
     
     

    Further information 

    Further information 
    Further information 
  • Video recording of the meeting (9:30-10:30am, 04.02.2021)  Video recording of the meeting (9:30-10:30am, 04.02.2021) 
  • Downloadable video with statement of Chair Tomas Tobé  Downloadable video with statement of Chair Tomas Tobé 
  • Committee on Development  Committee on Development 
     
     
     
     
     

    Productinformatie 

    REF.:  20210201IPR96811 

    Productinformatie 

    Productinformatie 
    Productinformatie 
    Productinformatie 
    REF.:  20210201IPR96811 
    REF.:  20210201IPR96811 
    REF.: REF.:REF.: 20210201IPR96811 20210201IPR96811 

    Deel deze pagina: 

    Deel deze pagina: 
    Deel deze pagina: 
  • Facebook Facebook 
  • Twitter Twitter 
  • LinkedIn LinkedIn 
  • Whatsapp Whatsapp Aanmelden voor e-mailupdatesAanmelden voor e-mailupdatesPdf-versie Pdf-versie 

    Voettekst 

    Voettekst Nieuws  Bekijk het menu: nieuws  Bekijk het menu: nieuws 
    Het Parlement in uw land 
  • Brussels  
  • Brussels   Brussels 
  • Den Haag  
  • Den Haag   Den Haag Tools 
  • Wetgevingsobservatorium  
  • Wetgevingsobservatorium   Wetgevingsobservatorium 
  • Multimedia Centre  
  • Multimedia Centre   Multimedia Centre 
  • EbS  
  • EbS   EbS 
    De Voorzitter van het Europees Parlement 
  • Webpagina van de Voorzitter van het Parlement  
  • Webpagina van de Voorzitter van het Parlement   Webpagina van de Voorzitter van het Parlement  Menu verbergen: Nieuws   Menu verbergen: Nieuws Europees Parlement  Menu bekijken: Europees Parlement   Menu bekijken: Europees Parlement 
  • Nieuws 
  • Nieuws  Nieuws 
  • Leden 
  • Leden  Leden 
  • Over het Parlement 
  • Over het Parlement  Over het Parlement 
  • Plenaire vergadering 
  • Plenaire vergadering  Plenaire vergadering 
  • Commissies 
  • Commissies  Commissies 
  • Delegaties 
  • Delegaties  Delegaties Menu verbergen: Europees Parlement Menu verbergen: Europees Parlement  

    Het Parlement in de sociale media  

    Het Parlement in de sociale media 
  • Facebook  
  • Facebook   Facebook 
  • Twitter  
  • Twitter   Twitter 
  • Facebook  
  • Facebook   Facebook 
  • LinkedIn  
  • LinkedIn   LinkedIn 
  • YouTube  
  • YouTube   YouTube 
  • Instagram  
  • Instagram   Instagram 
  • Pinterest  
  • Pinterest   Pinterest 
  • Snapchat  
  • Snapchat   Snapchat 
  • Reddit  
  • Reddit   Reddit Informatieve links 
  • Contact 
  • Contact Contact 
  • RSS 
  • RSS RSS 
  • Sitemap 
  • Sitemap Sitemap 
  • Juridische mededeling 
  • Juridische mededeling Juridische mededeling 
  • Privacybeleid 
  • Privacybeleid Privacybeleid 
  • Toegankelijkheid 
  • Toegankelijkheid Toegankelijkheid